CMS Recoupment of Medicare Advanced Payments Began March 30  

Claims recoupment for providers that received a Medicare Advanced and Accelerated Payment (AAP) will begin on the one-year anniversary from the date the provider received the payment. The Centers for Medicare & Medicaid Services (CMS) recently announced that the earliest recoupments for the first providers to receive an AAP payment began on March 30. In […]

Updates for the Week of March 29

The Centers for Medicare & Medicaid Services issued the following updates this week:​​​​ Hospital Outpatient Quality Reporting Checklist May 2021 Quarter 4 2020 Hospital Outpatient Quality Reporting Clinical Data Due May 3 Submission of Calendar Year 2020 Outpatient Web-based Measure Data Due May 17 Medicare Part A Cost Report: Easier File Uploads for e-Filing in […]

Medicare Sequester Relief Passes

Today, the U.S. Senate passed H.R. 1868 as amended, which will continue to delay the implementation of the 2% Medicare sequester until the end of the 2021 calendar year. The House passed the bill last week.   Without action by the House and Senate, the Medicare sequester was set to resume on April 1. The House version included additional […]

CHA Comments on CY 2019 Outpatient PPS Proposed Rule

CHA has submitted the attached comment letter on the calendar year (CY) 2019 outpatient prospective payment system (OPPS) proposed rule. In reviewing the policy and payment proposals outlined in the proposed rule, CHA is concerned that the agency has taken steps that are not only unlawful, but threaten the financial stability of the hospital OPPS and, in turn, access to care for Medicare beneficiaries. In particular, CHA strongly opposes CMS’ proposals to expand site-neutral payment policies for off-campus provider-based departments (PBDs) and to expand payment cuts for non-excepted PBDs participating in the 340B Drug Pricing Program. In addition, CHA provides comments on a number of other proposed payment and policy provisions. Specifically, CHA:

Urges CMS to withdraw all three of its proposals to expand site-neutral payment policies in off-campus PBDs
Opposes CMS’ proposal to reduce payments for separately payable Part B drugs from wholesale acquisition cost (WAC) plus 6 percent to WAC plus 3 percent